Drug Type Small molecule drug |
Synonyms LCI-133 |
Action inhibitors |
Mechanism AURK inhibitors(Serine/threonine-protein kinase Aurora inhibitors), CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Preclinical | United States | 28 Apr 2025 | |
Endometrial Carcinoma | Preclinical | United States | 31 May 2023 |